All posts by: Michael Zand

About Michael Zand

‘Bubble Boy’ Disease Cured With Stem Cells – TIME

Continue reading

2014-11-19 NEWS

TIME

‘Bubble Boy’ Disease Cured With Stem Cells
TIME
But doctors at University of California Los Angeles (UCLA) Broad Stem Cell Research Center gave her a new treatment, using her own stem cells, that has essentially cured her disease. She’s one of 18 children who have been treated with the cutting-edge …

and more »

Continue reading

2014-11-19 NEWS

TIME

‘Bubble Boy’ Disease Cured With Stem Cells
TIME
But doctors at University of California Los Angeles (UCLA) Broad Stem Cell Research Center gave her a new treatment, using her own stem cells, that has essentially cured her disease. She’s one of 18 children who have been treated with the cutting-edge …

and more »

Continue reading

2014-11-19 NEWS

ABC News

UCLA StemCell Researcher Cures Children With ‘Bubble Baby’ Disease
KTLA
A UCLA medical researcher was lauded Tuesday for developing a new stemcell gene-therapy treatment that has cured 18 children with “bubble baby” disease, meaning they were born without an immune system. Dr. Donald Kohn’s gene therapy used the …
UCLA Stem Cell Researcher Pioneers Gene Therapy Cure for Children with Newswise (press release)
UCLA Doctors Hail Potential Cure For ‘Bubble Baby’ SyndromeCBS Local
UCLA doctor finds gene therapy cure for ‘Bubble Baby’ childrenNew York Daily News
KTIC
all 7 news articles »
Continue reading

2014-11-18 NEWS

Bidness ETC

NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac StemCell
TheStreet.com
The stemcell therapy comes from a patient’s own bone marrow and is injected into patients after a heart attack. The stem cells are then supposed to help blood flow and build cardiac muscle. NeoStem’s trial used non-invasive imaging to monitor blood
Why NeoStem (NBS) Stock Might Decline TodayBidness ETC
NeoStem Announces Initial Positive Data from Phase 2 PreSERVE AMI Clinical Nasdaq

all 12 news articles »

Continue reading

2014-11-18 NEWS

Bidness ETC

NeoStem’s Stem Cell Therapy Fails Mid-Stage Heart Attack Study
TheStreet.com
Inject a cocktail of undifferentiated stem cells into a patient who has suffered a heart attack, and days or even weeks later, the stem cells transform into cardiac cells and rebuild the damaged heart muscle. Months later, the patient has a “new
Why NeoStem (NBS) Stock Might Decline TodayBidness ETC
NeoStem Announces Initial Positive Data from Phase 2 PreSERVE AMI Clinical CNNMoney

all 11 news articles »